Delivery Order SPE2DB22D3301-SPE2DB25FX5WS

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a Delivery Order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,858.35 firm fixed-price contract is for the delivery of 4566915162 - VORICONAZOLE 200 MG TABLET 30S, with a period of performance through January 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,932.13 firm-fixed-price delivery order is for the supply of 4555566119 - VORICONAZOLE 200 MG TABLET 30S. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,656.35 firm fixed-price delivery order is for the supply of 4,566,945,542 units of the pharmaceutical drug Voriconazole 200 mg Tablet, with a period of performance through January 16, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,811.12, is for the delivery of VORICONAZOLE 200 MG TABLET 30S, a pharmaceutical product, with a performance period through August 27, 2024. The award is a Delivery Order issued under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support...
This federal contract award is for the delivery of VORICONAZOLE 200 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $1,659.47. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $54,687.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for Firm Fixed Price pharmaceutical products, specifically VORANIGO 40 MG TABLET 30S. The award has an ultimate completion date of February 27, 2025. This contract is not designated as a set-aside procurement. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $27,094.95 firm fixed-price delivery order is for the supply of VORANIGO 40 MG TABLET 30S, which are likely pharmaceutical products. The contract has a period of performance through March 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,538,549,458 units of Voriconazole 200mg tablets, which are used to treat fungal infections. The contract has a ceiling value of $77,975.18 and a period of performance through August 2, 2017. It is a Firm Fixed Price Delivery Order contract, with no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,493.97 firm fixed-price delivery order is for the supply of 20 DRAM 1-CLIC AMBER VIALS. The contract has an ultimate completion date of March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,443.38 Firm Fixed Price Delivery Order is for the supply of VABOMERE 2 gram vials, a pharmaceutical product. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX5WS
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $2,080.74 awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4566516824 - VORICONAZOLE 40 MG/ML SUSP 75ML, a specialty pharmaceutical product.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

This specific delivery order does not have a set-aside designation, indicating open competition. The award has a period of performance through November 2024, with the final completion date on November 22, 2024.

Generated 2/20/25, 9:29 AM